99mTc-novobiocin: A novel radiotracer for infection imaging

Radiochimica Acta

Volumn 99, Issue 1, 2011, Pages 53-58

  Shah, S Q ^a   Khan, M R ^a   Khan, A U ^b  

^a UNIVERSITY OF PESHAWAR   (Pakistan)

^b PAKISTAN ATOMIC ENERGY COMMISSION   (Pakistan)

Author keywords

Infection; Inflammation; Novobiocin; Radiochemical purity; Technetium 99m

Indexed keywords

EID: 79551683270     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.2011.1790     Document Type: Article

References (35)

1. Bruggen, W., Bleeker-Rovers, C. P., Boerman, O. C., Gotthardt, M., Oyen, W. J. G.: PET and SPECT in osteomyelitis and prosthetic bone and joint infections: A systematic review. Semin. Nucl. Med. 40, 3(2010).
2. Basu, S., Chryssikos, T., Moghadam-Kia, S., Zhuang, H., Torigian, D. A., Alvai, A.: Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin. Nucl. Med. 39, 36(2009).
3. 99mTc-UBI: a comparative biodistribution study. Nucl. Med. Biol. 36, 57(2009)
4. 99mTc stannous colloid. Nucl. Med. Biol. 35, 707(2008).
5. Abushhiwa, M. H., Salehi, N. S., Lichtenstein, M., Lording, P. M., Finnin, P. J., Whitton, R. C., Charles, J. A., Parry, B. W.: Biodistribution of canine leucocytes labelled with technetium-99m stannous fluoride colloid in whole blood and their ability to localise to sites of induced inflammation. Vet. J. 185, 157(2010).
6. 199Tl-poly (N-vinylpyrrolidone) complexes. Appl. Radiat. Isot. 65, 309(2007).
7. 99mTc]-technetium stannous colloid is complement receptor 3-mediated and increases the neutrophil priming response to lipopolysaccharide. Nucl. Med. Biol. 33, 433(2006).
8. Laplaud, D. A., Berthelot, L., Miqueu, P., Bourcier, K., Moynard, J., Oudinet, Y., Guillet, M., Ruiz, C., Oden, N., Brouard, S., Guttmann, C. R., Weiner, H. L., Khoury, S. J., Soulillou, J. P.: Serial blood T cell repertoire alterations in multiple sclerosis patients, correlation with clinical and MRI parameters. J. Neuroimmunol. 177, 151(2006).
9. 99mTc-Alafosfalin: an antibiotic peptide infection imaging agent. Nucl. Med. Biol. 30, 169(2003).
10. 123I- labeled 2-methyl-4-nitroimidazole derivatives as potential infection imaging agents. Nucl. Med. Biol. 32, 385(2005).
11. 67Ga. Rev. Esp. Med. Nucl. 24, 322(2005).
12. Jackowski, C., Dirnhofer, S., Thali, M., Aghayev, E., Dirnhofer, R., Sonnenschein, M.: Postmortem diagnostics using MSCT and MRI of a lethal Streptococcus group A infection at infancy: a case report. Forensic. Sci. Int. 151, 157(2005).
13. 99mTc-labeled bacteriophages for infectionspecific imaging. Nucl. Med. Biol. 35, 433(2008).
14. 67Ga- citrate for the scintigraphic visualization of inflammatory lesions. Nucl. Med. Biol. 20, 881(1993).
15. 99mTc-labeled ciprofloxacin in mice. Chin. Med. J. 122, 1907(2009).
16. 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J. Nucl. Med. 44, 920(2003).
17. 99mTc-ciprofloxacin by different methods and its biodistribution. Appl. Radiat. Isot. 57, 193(2002).
18. 99mTcN complex of ciprofloxacin dithiocarbamate as a potential agent for infection imaging. Bioorg. Med. Chem. Lett. 18, 5168(2008).
19. 99mTc-cefoperazone complex, a novel agent for detecting sites of infection. J. Radioanal. Nucl. Chem. 272, 167(2007).
20. 99mTc-olfloxacin complex. J. Radioanal. Nucl. Chem. 272, 95(2007).
21. 99mTccefuroxime axetil. J. Radioanal. Nucl. Chem. 277, 491(2008).
22. 99mTc-pefloxacin: a new targeting agent for infectious foci. J. Radioanal. Nucl. Chem. 266, 131(2005).
23. 99mTc-kanamycin. J. Radioanal. Nucl. Chem. 267, 561(2006).
24. 99mTc-sparafloxacin complex, a novel agent for detecting sites of infection. J. Label. Compd. Radiopharm. 52, 415(2009).
25. 99mTc- moxifloxacin, a potential infection specific imaging agent. Appl. Radiat. Isot. 68, 314(2010).
26. 99mTc-sitafloxacin kit: a novel infection imaging agent. J. Radioanal. Nucl. Chem. 284, 189(2010).
27. García, I. G., Stevenson, C. E. M., Usón, I., Meyers, C. L. F., Walsh, C. T., Lawson, D. M.: The crystal structure of the novobiocin biosynthetic enzyme NovP: the first representative structure for the TylF O-methyltransferase superfamily. J. Mol. Biol. 395, 390(2010).
28. Inoue, K., Nitta, S., Hino, T., Oka, H.: LC-MS/MS and centrifugal ultrafiltration method for the determination of novobiocin in chicken, fish tissues, milk and human serum. J. Chromatogr. B 877, 461(2009).
29. Jung, W. S., Shin, S., Park, I. K.: Novobiocin inhibits the selfsplicing of the primary transcripts of T4 phage thymidylate synthase gene. Mol. Cell. Biochem. 314, 143(2008).
30. Dangel, V., Eustáquio, A. S., Gust, B., Heide, L.: novE and novG act as positive regulators of novobiocin biosynthesis. Arch. Microbiol. 190, 509(2008).
31. Vecchio, M. D., Balducci, E.: Mono ADP-ribosylation inhibitors prevent inflammatory cytokine release in alveolar epithelial cells. Mol. Cell. Biochem. 310, 77(2008).
32. Singh, G., Jayanarayan, K. G., Dey, C. S.: Novobiocin induces apoptosis-like cell death in topoisomerase II over-expressing arsenite resistant Leishmania donovani. Mol. Biochem. Parasit. 141, 57(2005).
33. 99mTc-ciprofloxacin. J. Nucl. Med. 45, 2088(2004).
34. Johannsen, B., Spies, H.: Progress and problems in the chemistry of technetium-99m tracers. Isotopenpraxis 24, 449(1988).
35. Kieviet, W.: Technetium radiopharmaceuticals: Chemical characterization and tissue biodistribution of Tc-glucoheptonate using Tc-99m and carrier Tc-99. J. Nucl. Med. 22, 703(1981).